Article info
PDFClinical ethics
Multivalue ethical framework for fair global allocation of a COVID-19 vaccine
- Correspondence to Ms Yangzi Liu, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; yangzi.liu{at}vanderbilt.edu
Citation
Multivalue ethical framework for fair global allocation of a COVID-19 vaccine
Publication history
- Received May 27, 2020
- Accepted June 4, 2020
- First published June 12, 2020.
Online issue publication
July 23, 2020
Article Versions
- Previous version (12 June 2020).
- Previous version (14 July 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Other content recommended for you
- Vaccine equity in COVID-19: a meta-narrative review
- Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- Ethical allocation of future COVID-19 vaccines
- Are asylum seekers, refugees and foreign migrants considered in the COVID-19 vaccine discourse?
- Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study
- An intersectional human rights approach to prioritising access to COVID-19 vaccines
- A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review
- ‘VaxTax’: a follow-up proposal for a global vaccine pandemic response fund
- WHO’s allocation framework for COVAX: is it fair?